Phuong Khanh Morrow - Chief Medical Officer at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Phuong Khanh Morrow since 08 Feb 2025

Holdings reported by Phuong Khanh Morrow for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 4,411 $275,700 $62.50 24 May 2023 Direct
Restricted Stock Units 20,812 23 May 2023 Direct Common Shares
Stock Option (Right to Buy) 16,667 13 Oct 2023 Direct Common Shares

Transactions reported by Phuong Khanh Morrow for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.